Anteris Technologies Global (AVR) Cash from Financing Activities (2024 - 2026)
Anteris Technologies Global (AVR) reported Cash from Financing Activities of $299.5 million for Q1 2026, up 27552.89% year-over-year from N/an in Q1 2025, and up 1238.18% quarter-over-quarter from $22.4 million in Q4 2025.
Anteris Technologies Global (AVR) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has 3 years of Cash from Financing Activities data on file, last reported at $299.5 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $299.5 million, up 27552.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $321.2 million (up 191.46% YoY), and the FY2025 annual result was $20.6 million, down 81.78% from the prior year.
- Cash from Financing Activities advanced to $299.5 million in Q1 2026 per AVR's latest filing, from $22.4 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $299.5 million in Q1 2026 and troughed at -$1.1 million in Q1 2025.
- A 3-year average of $48.1 million and a median of $14.4 million in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities sank 170.25% in 2025, then soared 27552.89% in 2026.
- A 3-year view of Cash from Financing Activities shows it stood at $78.4 million in 2024, then tumbled by 71.45% to $22.4 million in 2025, then soared by 1238.18% to $299.5 million in 2026.
- Business Quant data shows AVR's Cash from Financing Activities at $299.5 million in Q1 2026, $22.4 million in Q4 2025, and -$294000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Anteris Technologies Global | 779.46 Mn | 779.43 Mn | 380,000.00 | 299.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299.51 Mn |
| Mar 31, 2026 | 299.51 Mn |
| Dec 31, 2025 | 22.38 Mn |
| Dec 31, 2025 | 22.38 Mn |
| Sep 30, 2025 | -294,000.00 |
| Sep 30, 2025 | -294,000.00 |
| Jun 30, 2025 | -442,000.00 |
| Jun 30, 2025 | -442,000.00 |
| Mar 31, 2025 | -1.09 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | 78.40 Mn |
| Dec 31, 2024 | 78.40 Mn |
| Sep 30, 2024 | 18.49 Mn |
| Sep 30, 2024 | 18.49 Mn |
| Jun 30, 2024 | 14.39 Mn |
| Jun 30, 2024 | 14.39 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |